GL1X · GenesisL1 explorer

MolNFT v1 · #124670 · protein

Human histidine triad nucleotide binding protein 1 (HHINT1) H112N mutant adenosine nucleoside phosphoramidate substrate complex

5KLY · Histidine triad nucleotide-binding protein 1: “Human histidine triad nucleotide binding protein 1 (HHINT1) H112N mutant adenosine nucleoside phosphoramidate…”. X-ray diffraction, 2 ligands (6UR, CL), 2 pockets (best druggability…

PDB
5KLY
Type
protein
Length
227 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Histidine triad nucleotide-binding protein 1
EC
3.-.-.-
UniProt
P49773
Ligands
6UR, CL
Pockets
2 · best druggability 0.40

Structure

x-ray diffraction · 2 distinct chains · 29% helix, 25% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
AHistidine triad nucleotide-binding protein 1 (EC 3.-.-.-)protein11529% helix, 24% strandP49773
BHistidine triad nucleotide-binding protein 1 (EC 3.-.-.-)protein11229% helix, 25% strandP49773

Ligands and binding sites

  • 6UR · [(2~{R},3~{S},4~{R},5~{R})-5-(6-aminopurin-9-yl)-3,4-bis(oxidanyl)oxolan-2-yl]methoxy-~{N}-[2-(1~{H}-indol-3-yl)ethyl]phosphonamidic acid · ligand · chains A, B
  • CL · Chloride ion · ion · chains B
  • PEG · Di(hydroxyethyl)ether · additive · chains A, B

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

2 pockets found on a 1 Å grid, 0 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
11010.400.76276UR
2810.330.7421empty

Interfaces

1 interface between chains.

  • A–B · 1994 Ų buried · 43 hydrogen bonds · protein-protein

Compared structures

  • 5KLY · Human Histidine Triad Nucleotide Binding Protein 1 (hHint1) H112N mutant adenosine… · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.